Login Register Cart 0
Review Article

隐形眼镜配戴者的眼泪炎症分子：文献综述。

卷 27, 期 4, 2020

页: [523 - 548] 页: 26

弟呕挨: 10.2174/0929867326666190409152921

价格: $65

摘要

背景：大量研究已经分析了使用不同的隐形眼镜（CL）或护理液的影响，以及与CL佩戴相关的不适或疾病，这些炎症或炎性介质释放到眼泪中。目的：总结与CL使用相关的眼泪炎症分子的公开数据。 方法：进行PubMed-NCBI检索，选择那些进行原始调查的出版物，包括分析CL佩戴者的泪液炎症介质。 结果：1990年至2019年共收录了43篇文章。据报道，佩戴水凝胶CL，坚硬的透气性CL和圆锥形角膜患者不规则角膜的特殊设计（圆锥形圆锥形CL，混合性CL，背负式和巩膜性CL）可改变眼泪中几种分子的浓度。而且，似乎会影响佩戴时间和时间表，CL材料和设计以及所用的护理液。关于CL不适，其与炎性介质的关系尚不清楚。但是，一些与CL磨损相关的疾病，例如巨乳头结膜炎，CL引起的急性红眼，CL引起的周围性溃疡和棘阿米巴角膜炎，与某些炎症介质的释放有关，这些介质可能是潜在的生物标志物。 结论：有证据表明，CL佩戴的不同方面改变了眼泪中的炎症介质分布，这可能表明泪液功能单元处于炎症状态。但是，需要进行更多的研究，以更好地了解这种炎症过程如何发挥作用，以及对CL磨损不同方面的影响。

关键词: 隐形眼镜，泪液，炎症，介质，生物标志物，分子，CL不适。

« Previous Next »
[1]
Zhou, L.; Beuerman, R.W. Tear analysis in ocular surface diseases. Prog. Retin. Eye Res., 2012, 31(6), 527-550.
[http://dx.doi.org/10.1016/j.preteyeres.2012.06.002] [PMID: 22732126]
[2]
von Thun Und Hohenstein-Blaul, N.; Funke, S.; Grus, F.H. Tears as a source of biomarkers for ocular and systemic diseases. Exp. Eye Res., 2013, 117, 126-137.
[http://dx.doi.org/10.1016/j.exer.2013.07.015] [PMID: 23880526]
[3]
Hagan, S.; Martin, E.; Enríquez-de-Salamanca, A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J., 2016, 7, 15.
[http://dx.doi.org/10.1186/s13167-016-0065-3] [PMID: 27413414]
[4]
Borish, L.C.; Steinke, J.W. 2. Cytokines and chemokines. J. Allergy Clin. Immunol., 2003, 111(2)(Suppl.), S460-S475.
[http://dx.doi.org/10.1067/mai.2003.108] [PMID: 12592293]
[5]
Thacker, M.A.; Clark, A.K.; Marchand, F.; McMahon, S.B. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth. Analg., 2007, 105(3), 838-847.
[http://dx.doi.org/10.1213/01.ane.0000275190.42912.37] [PMID: 17717248]
[6]
Üçeyler, N.; Sommer, C. Cytokine-induced pain: basic science and clinical implications. Rev. Analg., 2007, 9(2), 87-103.
[http://dx.doi.org/10.3727/000000007783992807]
[7]
Niederkorn, J.Y.; Peeler, J.S.; Mellon, J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol., 1989, 2(2), 83-90.
[PMID: 2641920]
[8]
Tanaka, T.; Kishimoto, T. The biology and medical implications of interleukin-6. Cancer Immunol. Res., 2014, 2(4), 288-294.
[http://dx.doi.org/10.1158/2326-6066.CIR-14-0022] [PMID: 24764575]
[9]
Cubitt, C.L.; Tang, Q.; Monteiro, C.A.; Lausch, R.N.; Oakes, J.E. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci., 1993, 34(11), 3199-3206.
[PMID: 7691777]
[10]
Wilson, S.E.; Liang, Q.; Kim, W.J. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest. Ophthalmol. Vis. Sci., 1999, 40(10), 2185-2190.
[PMID: 10476782]
[11]
Kasemkijwattana, C.; Menetrey, J.; Bosch, P.; Somogyi, G.; Moreland, M.S.; Fu, F.H.; Buranapanitkit, B.; Watkins, S.S.; Huard, J. Use of growth factors to improve muscle healing after strain injury. Clin. Orthop. Relat. Res., 2000, (370), 272-285.
[http://dx.doi.org/10.1097/00003086-200001000-00028] [PMID: 10660723]
[12]
Taipale, J.; Saharinen, J.; Keski-Oja, J. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv. Cancer Res., 1998, 75, 87-134.
[http://dx.doi.org/10.1016/S0065-230X(08)60740-X] [PMID: 9709808]
[13]
Sivak, J.M.; Fini, M.E. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog. Retin. Eye Res., 2002, 21(1), 1-14.
[http://dx.doi.org/10.1016/S1350-9462(01)00015-5] [PMID: 11906808]
[14]
Gordon, G.M.; Ledee, D.R.; Feuer, W.J.; Fini, M.E. Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells. J. Cell. Physiol., 2009, 221(2), 402-411.
[http://dx.doi.org/10.1002/jcp.21869] [PMID: 19626678]
[15]
Borgeat, P.; Samuelsson, B. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. Proc. Natl. Acad. Sci. USA, 1979, 76(7), 3213-3217.
[http://dx.doi.org/10.1073/pnas.76.7.3213] [PMID: 290996]
[16]
Huang, W.W.; Garcia-Zepeda, E.A.; Sauty, A.; Oettgen, H.C.; Rothenberg, M.E.; Luster, A.D. Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J. Exp. Med., 1998, 188(6), 1063-1074.
[http://dx.doi.org/10.1084/jem.188.6.1063] [PMID: 9743525]
[17]
Lee, K.S.; Kim, S.R.; Park, H.S.; Jin, G.Y.; Lee, Y.C. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J. Allergy Clin. Immunol., 2004, 114(5), 1093-1099.
[http://dx.doi.org/10.1016/j.jaci.2004.07.039] [PMID: 15536415]
[18]
Sack, R.; Conradi, L.; Beaton, A.; Sathe, S.; McNamara, N.; Leonardi, A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp. Eye Res., 2007, 85(4), 528-538.
[http://dx.doi.org/10.1016/j.exer.2007.07.004] [PMID: 17719576]
[19]
LaFrance, M.W.; Kehinde, L.E.; Fullard, R.J. Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay. Curr. Eye Res., 2008, 33(7), 525-544.
[http://dx.doi.org/10.1080/02713680802190085] [PMID: 18600485]
[20]
Carreño, E.; Enríquez-de-Salamanca, A.; Tesón, M.; García-Vázquez, C.; Stern, M.E.; Whitcup, S.M.; Calonge, M. Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol., 2010, 88(7), e250-e258.
[http://dx.doi.org/10.1111/j.1755-3768.2010.01978.x] [PMID: 20738261]
[21]
Benito, M.J.; González-García, M.J.; Tesón, M.; García, N.; Fernández, I.; Calonge, M.; Enríquez-de-Salamanca, A. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects. Exp. Eye Res., 2014, 120, 43-49.
[http://dx.doi.org/10.1016/j.exer.2013.12.017] [PMID: 24412438]
[22]
Enríquez-de-Salamanca, A.; Bonini, S.; Calonge, M. Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr. Opin. Allergy Clin. Immunol., 2012, 12(5), 523-533.
[http://dx.doi.org/10.1097/ACI.0b013e328357b488] [PMID: 22895048]
[23]
Enríquez-de-Salamanca, A.; Calonge, M. Cytokines and chemokines in immune-based ocular surface inflammation. Expert Rev. Clin. Immunol., 2008, 4(4), 457-467.
[http://dx.doi.org/10.1586/1744666X.4.4.457] [PMID: 20477574]
[24]
Lam, H.; Bleiden, L.; de Paiva, C.S.; Farley, W.; Stern, M.E.; Pflugfelder, S.C. Tear cytokine profiles in dysfunctional tear syndrome. Am. J. Ophthalmol., 2009, 147, 198-205.
[http://dx.doi.org/10.1016/j.ajo.2008.08.032] [PMID: 18992869]
[25]
Enríquez-de-Salamanca, A.; Castellanos, E.; Stern, M.E.; Fernández, I.; Carreño, E.; García-Vázquez, C.; Herreras, J.M.; Calonge, M. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol. Vis., 2010, 16, 862-873.
[PMID: 20508732]
[26]
Riemens, A.; Stoyanova, E.; Rothova, A.; Kuiper, J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol. Vis., 2012, 18, 797-802.
[PMID: 22509110]
[27]
Jung, J.W.; Han, S.J.; Song, M.K.; Kim, T.I.; Kim, E.K.; Min, Y.H.; Cheong, J.W.; Seo, K.Y. Tear cytokines as biomarkers for chronic graft-versus-host disease. Biol. Blood Marrow Transplant., 2015, 21(12), 2079-2085.
[http://dx.doi.org/10.1016/j.bbmt.2015.08.020] [PMID: 26303101]
[28]
Cocho, L.; Fernández, I.; Calonge, M.; Martínez, V.; González-García, M.J.; Caballero, D.; López-Corral, L.; García-Vázquez, C.; Vázquez, L.; Stern, M.E.; Enríquez-de-Salamanca, A. Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model. Invest. Ophthalmol. Vis. Sci., 2016, 57(2), 746-758.
[http://dx.doi.org/10.1167/iovs.15-18615] [PMID: 26927568]
[29]
Cocho, L.; Fernández, I.; Calonge, M.; Sainz de la Maza, M.; Rovira, M.; Stern, M.E.; Garcia-Vazquez, C.; Enríquez-de-Salamanca, A. Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic graft-versus-host disease. Invest. Ophthalmol. Vis. Sci., 2017, 58(11), 4836-4846.
[http://dx.doi.org/10.1167/iovs.17-21670] [PMID: 28973330]
[30]
Tesón, M.; González-García, M.J.; López-Miguel, A.; Enríquez-de-Salamanca, A.; Martín-Montañez, V.; Benito, M.J.; Mateo, M.E.; Stern, M.E.; Calonge, M. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest. Ophthalmol. Vis. Sci., 2013, 54(3), 2093-2099.
[http://dx.doi.org/10.1167/iovs.12-11361] [PMID: 23412090]
[31]
López-Miguel, A.; Tesón, M.; Martín-Montañez, V.; Enríquez-de-Salamanca, A.; Stern, M.E.; Calonge, M.; González-García, M.J. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am. J. Ophthalmol., 2014, 157(4), 788-798.e2.
[http://dx.doi.org/10.1016/j.ajo.2014.01.001] [PMID: 24412126]
[32]
López-Miguel, A.; Tesón, M.; Martín-Montañez, V.; Enríquez-de-Salamanca, A.; Stern, M.E.; González-García, M.J.; Calonge, M. Clinical and molecular inflammatory response in sjögren syndrome-associated dry eye patients under desiccating stress. Am. J. Ophthalmol., 2016, 161, 133-41.e2.
[http://dx.doi.org/10.1016/j.ajo.2015.09.039] [PMID: 26456254]
[33]
Calonge, M.; Pinto-Fraga, J.; González-García, M.J.; Enríquez-de-Salamanca, A.; López-de la Rosa, A.; Fernández, I.; López-Miguel, A. Effects of the external environment on dry eye disease. Int. Ophthalmol. Clin., 2017, 57(2), 23-40.
[http://dx.doi.org/10.1097/IIO.0000000000000168] [PMID: 28282312]
[34]
Calonge, M.; Labetoulle, M.; Messmer, E.M.; Shah, S.; Akova, Y.A.; Boboridis, K.G.; Merayo-Lloves, J.; Aragona, P.; Benítez-Del-Castillo, J.; Geerling, G.; Rolando, M.; Baudouin, C. Controlled adverse environment chambers in dry eye research. Curr. Eye Res., 2018, 43(4), 445-450.
[http://dx.doi.org/10.1080/02713683.2017.1420197] [PMID: 29336696]
[35]
Morgan, P.B.; Woods, C.A.; Tranoudis, I.G.; Helland, M.; Efron, N.; Jones, L.; van Beusekom, M.; Grupcheva, C.N.; Jones, D.; Beeler-Kaupke, M.; Qi, P.; Tan, K.O.; Krasnanska, J.; Pult, H.; Ravn, O.; Santodomingo-Rebido, J.; Végh, M.; Fan, C.H.; Erdinets, N.; Jafari, A.R.; Montani, G.; Itoi, M.; Chu, S.B.; Bendoriene, J.; Ziziuchin, V.; van der Worp, E.; Lam, W.; Romualdez-Oo, J.; Abesamis-Dichoso, C.; González-Méijone, J.M.; Belousov, V.; Gierow, P.; Stabuc Silih, M.; Hsiao, J.; Nichols, J.J. International contact lens prescribing in 2016. Contact Lens Spectr., 2017, 32, 30-35.
[36]
Willcox, M.D.; Zhao, Z.; Naduvilath, T.; Lazon de la Jara, P. Cytokine changes in tears and relationship to contact lens discomfort. Mol. Vis., 2015, 21, 293-305.
[PMID: 25814827]
[37]
Markoulli, M.; Papas, E.; Cole, N.; Holden, B. Effect of contact lens wear on the diurnal profile of matrix metalloproteinase 9 in tears. Optom. Vis. Sci., 2013, 90(5), 419-429.
[http://dx.doi.org/10.1097/OPX.0b013e31828d7d3b] [PMID: 23563442]
[38]
Yucekul, B.; Mocan, M.C.; Kocabeyoglu, S.; Tan, C.; Irkec, M. Evaluation of long-term silicone hydrogel use on ocular surface inflammation and tear function in patients with and without meibomian gland dysfunction. Eye Contact Lens, 2019, 45(1), 61-66.
[http://dx.doi.org/10.1097/ICL.0000000000000526] [PMID: 29944505]
[39]
Dogru, M.; Ward, S.K.; Wakamatsu, T.; Ibrahim, O.; Schnider, C.; Kojima, T.; Matsumoto, Y.; Ogawa, J.; Shimazaki, J.; Tsubota, K. The effects of 2 week senofilcon-A silicone hydrogel contact lens daily wear on tear functions and ocular surface health status. Cont. Lens Anterior Eye, 2011, 34(2), 77-82.
[http://dx.doi.org/10.1016/j.clae.2010.12.001] [PMID: 21190890]
[40]
Poyraz, C.; Irkec, M.; Mocan, M.C. Elevated tear interleukin-6 and interleukin-8 levels associated with silicone hydrogel and conventional hydrogel contact lens wear. Eye Contact Lens, 2012, 38(3), 146-149.
[http://dx.doi.org/10.1097/ICL.0b013e3182482910] [PMID: 22415150]
[41]
Yüksel Elgin, C.; İskeleli, G.; Talaz, S.; Akyol, S. Comparative analysis of tear film levels of inflammatory mediators in contact lens users. Curr. Eye Res., 2016, 41(4), 441-447.
[PMID: 26079169]
[42]
Chao, C.; Stapleton, F.; Willcox, M.D.P.; Golebiowski, B.; Richdale, K. Preinflammatory Signs in established reusable and disposable contact lens wearers. Optom. Vis. Sci., 2017, 94(11), 1003-1008.
[http://dx.doi.org/10.1097/OPX.0000000000001129] [PMID: 28858005]
[43]
Thakur, A.; Willcox, M.D. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp. Eye Res., 2000, 70(3), 255-259.
[http://dx.doi.org/10.1006/exer.1999.0767] [PMID: 10712811]
[44]
Barba Gallardo, L.F.; Muñoz Ortega, M.H.; Ventura Juarez, J.; Aldaba Muruato, L.R.; Sánchez Alemán, E.; Valdez Morales, E.E.; Blancas Zugarazo, S.S.; Villafan Bernal, J.R. Extended low oxygen transmissibility contact lens use induces alterations in the concentration of proinflammatory cytokines, enzymes and electrolytes in tear fluid. Exp. Ther. Med., 2018, 15(5), 4291-4297.
[http://dx.doi.org/10.3892/etm.2018.5989] [PMID: 29849773]
[45]
Kallinikos, P.; Morgan, P.; Efron, N. Assessment of stromal keratocytes and tear film inflammatory mediators during extended wear of contact lenses. Cornea, 2006, 25(1), 1-10.
[http://dx.doi.org/10.1097/01.ico.0000167877.11687.7e] [PMID: 16331033]
[46]
González-Pérez, J.; Villa-Collar, C.; Sobrino Moreiras, T.; Lema Gesto, I.; González-Méijome, J.M.; Rodríguez-Ares, M.T.; Parafita, M. Tear film inflammatory mediators during continuous wear of contact lenses and corneal refractive therapy. Br. J. Ophthalmol., 2012, 96(8), 1092-1098.
[http://dx.doi.org/10.1136/bjophthalmol-2012-301527] [PMID: 22694966]
[47]
Jung, J.W.; Han, S.H.; Park, S.Y.; Kim, E.K.; Seo, K.Y.; Kim, T.I. Effects of pigment location in tinted contact lenses on the ocular surface. Optom. Vis. Sci., 2016, 93(8), 997-1003.
[http://dx.doi.org/10.1097/OPX.0000000000000880] [PMID: 27232903]
[48]
Martín-Montañez, V.; Enríquez-de-Salamanca, A.; López-de la Rosa, A.; López-Miguel, A.; Fernández, I.; Calonge, M.; González-Méijome, J.M.; González-García, M.J. Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear. Cornea, 2016, 35(9), 1192-1198.
[http://dx.doi.org/10.1097/ICO.0000000000000960] [PMID: 27442313]
[49]
van Setten, G.B.; Tervo, T.; Andersson, R.; Perheentupa, J.; Tarkkanen, A. Plasmin and epidermal growth factor in the tear fluid of contact-lens wearers: effect of wearing different types of contact lenses and association with clinical findings. Ophthalmic Res., 1990, 22(4), 233-240.
[http://dx.doi.org/10.1159/000267028] [PMID: 2150979]
[50]
Chao, C.; Golebiowski, B.; Stapleton, F.; Richdale, K. Changes in tear cytokine concentrations following discontinuation of soft contact lenses-A pilot study. Eye Contact Lens, 2016, 42(4), 237-243.
[http://dx.doi.org/10.1097/ICL.0000000000000182] [PMID: 26309026]
[51]
Schultz, C.L.; Kunert, K.S. Interleukin-6 levels in tears of contact lens wearers. J. Interferon Cytokine Res., 2000, 20(3), 309-310.
[http://dx.doi.org/10.1089/107999000312441] [PMID: 10762078]
[52]
Swarbrick, H.A. Orthokeratology review and update. Clin. Exp. Optom., 2006, 89(3), 124-143.
[http://dx.doi.org/10.1111/j.1444-0938.2006.00044.x] [PMID: 16637967]
[53]
Fodor, M.; Kolozsvári, B.L.; Petrovski, G.; Kettesy, B.A.; Gogolák, P.; Rajnavölgyi, É.; Ujhelyi, B.; Módis, L.; Petrovski, B.É.; Szima, G.Z.; Berta, A.; Facskó, A. Effect of contact lens wear on the release of tear mediators in keratoconus. Eye Contact Lens, 2013, 39(2), 147-152.
[http://dx.doi.org/10.1097/ICL.0b013e318273b35f] [PMID: 23411991]
[54]
Lema, I.; Durán, J.A.; Ruiz, C.; Díez-Feijoo, E.; Acera, A.; Merayo, J. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects. Cornea, 2008, 27(7), 758-763.
[http://dx.doi.org/10.1097/ICO.0b013e31816a3591] [PMID: 18650659]
[55]
González-Pérez, J.; Villa-Collar, C.; González-Méijome, J.M.; Porta, N.G.; Parafita, M.Á. Long-term changes in corneal structure and tear inflammatory mediators after orthokeratology and LASIK. Invest. Ophthalmol. Vis. Sci., 2012, 53(9), 5301-5311.
[http://dx.doi.org/10.1167/iovs.11-9155] [PMID: 22789928]
[56]
Downie, L.E.; Lindsay, R.G. Contact lens management of keratoconus. Clin. Exp. Optom., 2015, 98(4), 299-311.
[http://dx.doi.org/10.1111/cxo.12300] [PMID: 26104589]
[57]
Steele, C.; Davidson, J. Contact lens fitting post-laser-in situ keratomileusis (LASIK). Cont. Lens Anterior Eye, 2007, 30(2), 84-93.
[http://dx.doi.org/10.1016/j.clae.2006.12.005] [PMID: 17329148]
[58]
Pannebaker, C.; Chandler, H.L.; Nichols, J.J. Tear proteomics in keratoconus. Mol. Vis., 2010, 16, 1949-1957.
[PMID: 21031023]
[59]
Acar, B.T.; Vural, E.T.; Acar, S. Effects of contact lenses on the ocular surface in patients with keratoconus: piggyback versus ClearKone hybrid lenses. Eye Contact Lens, 2012, 38(1), 43-48.
[http://dx.doi.org/10.1097/ICL.0b013e31823ff181] [PMID: 22157394]
[60]
Carracedo, G.; Blanco, M.S.; Martin-Gil, A.; Zicheng, W.; Alvarez, J.C.; Pintor, J. Short-term effect of scleral lens on the dry eye biomarkers in keratoconus. Optom. Vis. Sci., 2016, 93(2), 150-157.
[http://dx.doi.org/10.1097/OPX.0000000000000788] [PMID: 26657697]
[61]
Lema, I.; Durán, J.A. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology, 2005, 112(4), 654-659.
[http://dx.doi.org/10.1016/j.ophtha.2004.11.050] [PMID: 15808258]
[62]
Jun, A.S.; Cope, L.; Speck, C.; Feng, X.; Lee, S.; Meng, H.; Hamad, A.; Chakravarti, S. Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS One, 2011, 6(1)e16437
[http://dx.doi.org/10.1371/journal.pone.0016437] [PMID: 21298010]
[63]
Kalsow, C.M.; Reindel, W.T.; Merchea, M.M.; Bateman, K.M.; Barr, J.T. Tear cytokine response to multipurpose solutions for contact lenses. Clin. Ophthalmol., 2013, 7, 1291-1302.
[http://dx.doi.org/10.2147/OPTH.S44642] [PMID: 23847409]
[64]
Nichols, K.K.; Redfern, R.L.; Jacob, J.T.; Nelson, J.D.; Fonn, D.; Forstot, S.L.; Huang, J.F.; Holden, B.A.; Nichols, J.J. Members of the TFOS International Workshop on Contact Lens Discomfort. The TFOS international workshop on contact lens discomfort: report of the definition and classification subcommittee. Invest. Ophthalmol. Vis. Sci., 2013, 54(11), TFOS14-19.
[http://dx.doi.org/10.1167/iovs.13-13074] [PMID: 24058134]
[65]
Richdale, K.; Sinnott, L.T.; Skadahl, E.; Nichols, J.J. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea, 2007, 26(2), 168-174.
[http://dx.doi.org/10.1097/01.ico.0000248382.32143.86] [PMID: 17251807]
[66]
López-de la Rosa, A.; Martín-Montañez, V.; López-Miguel, A.; Calonge, M.; Enríquez-de-Salamanca, A.; González-García, M.J. Corneal sensitivity and inflammatory biomarkers in contact lens discomfort. Optom. Vis. Sci., 2016, 93(8), 892-900.
[http://dx.doi.org/10.1097/OPX.0000000000000784] [PMID: 26636403]
[67]
Masoudi, S.; Zhao, Z.; Stapleton, F.; Willcox, M. Contact lens-induced discomfort and inflammatory mediator changes in tears. Eye Contact Lens, 2017, 43(1), 40-45.
[http://dx.doi.org/10.1097/ICL.0000000000000237] [PMID: 26808700]
[68]
Masoudi, S.; Stapleton, F.J.; Willcox, M.D.P. Differences in tear film biochemistry of symptomatic and asymptomatic lens wearers. Optom. Vis. Sci., 2017, 94(9), 914-918.
[http://dx.doi.org/10.1097/OPX.0000000000001110] [PMID: 28816866]
[69]
Liu, Q.; McDermott, A.M.; Miller, W.L. Elevated nerve growth factor in dry eye associated with established contact lens wear. Eye Contact Lens, 2009, 35(5), 232-237.
[http://dx.doi.org/10.1097/ICL.0b013e3181b3e87f] [PMID: 19672199]
[70]
Gad, A.; Vingrys, A.J.; Wong, C.Y.; Jackson, D.C.; Downie, L.E. Tear film inflammatory cytokine upregulation in contact lens discomfort. Ocul. Surf., 2019, 17(1), 89-97.
[http://dx.doi.org/10.1016/j.jtos.2018.10.004] [PMID: 30321605]
[71]
Igarashi, T.; Kobayashi, M.; Yaguchi, C.; Fujimoto, C.; Suzuki, H.; Takahashi, H. Efficacy of rebamipide instillation for contact lens discomfort with dry eye. Eye Contact Lens, 2018, 44(Suppl. 2), S137-S142.
[http://dx.doi.org/10.1097/ICL.0000000000000438] [PMID: 29135738]
[72]
Downie, L.E.; Gad, A.; Wong, C.Y.; Gray, J.H.V.; Zeng, W.; Jackson, D.C.; Vingrys, A.J. Modulating contact lens discomfort with anti-inflammatory approaches: a randomized controlled trial. Invest. Ophthalmol. Vis. Sci., 2018, 59(8), 3755-3766.
[http://dx.doi.org/10.1167/iovs.18-24758] [PMID: 30046817]
[73]
Azari, A.A.; Barney, N.P. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA, 2013, 310(16), 1721-1729.
[http://dx.doi.org/10.1001/jama.2013.280318] [PMID: 24150468]
[74]
Moschos, M.M.; Eperon, S.; Guex-Crosier, Y. Increased eotaxin in tears of patients wearing contact lenses. Cornea, 2004, 23(8), 771-775.
[http://dx.doi.org/10.1097/01.ico.0000133987.34274.c0] [PMID: 15502476]
[75]
Iwasaki, Y.; Shoji, J.; Inada, N.; Sawa, M. Evaluation of the chemokine variation in tears of contact lens wearers. Nippon Ganka Gakkai Zasshi, 2006, 110(9), 723-729.
[PMID: 17025230]
[76]
Sengör, T.; Irkeç, M.; Gülen, Y.; Taşeli, M.; Erker, H. Tear LTC4 levels in patients with subclinical contact lens related giant papillary conjunctivitis. CLAO J., 1995, 21(3), 159-162.
[PMID: 7586473]
[77]
Irkeç, M.T.; Orhan, M.; Erdener, U. Role of tear inflammatory mediators in contact lens-associated giant papillary conjunctivitis in soft contact lens wearers. Ocul. Immunol. Inflamm., 1999, 7(1), 35-38.
[http://dx.doi.org/10.1076/ocii.7.1.35.8107] [PMID: 10410873]
[78]
Tran, H.V.; Eperon, S.; Guex-Crosier, Y. Persistence of increased Eotaxin-1 (CCL11) level in tears of patients wearing contact lenses: a long-term follow-up study. Klin. Monatsbl. Augenheilkd., 2011, 228(4), 326-329.
[http://dx.doi.org/10.1055/s-0031-1273208] [PMID: 21484639]
[79]
Irkeç, M.; Orhan, M. Effect of extended wear disposable contact lenses on tear LTC4 in giant papillary conjunctivitis. Ocul. Immunol. Inflamm., 1995, 3(2), 107-112.
[http://dx.doi.org/10.3109/09273949509085038] [PMID: 22827277]
[80]
Elgebaly, S.A.; Donshik, P.C.; Rahhal, F.; Williams, W. Neutrophil chemotactic factors in the tears of giant papillary conjunctivitis patients. Invest. Ophthalmol. Vis. Sci., 1991, 32(1), 208-213.
[PMID: 1846131]
[81]
Holden, B.A.; La Hood, D.; Grant, T.; Newton-Howes, J.; Baleriola-Lucas, C.; Willcox, M.D.; Sweeney, D.F. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J., 1996, 22(1), 47-52.
[PMID: 8835069]
[82]
Thakur, A.; Willcox, M.D. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp. Eye Res., 1998, 67(1), 9-19.
[http://dx.doi.org/10.1006/exer.1998.0480] [PMID: 9702174]
[83]
Tan, M.; Thakur, A.; Morris, C.; Willcox, M.D. Presence of inflammatory mediators in the tears of contact lens wearers and non-contact lens wearers. Aust. N. Z. J. Ophthalmol., 1997, 25(Suppl. 1), S27-S29.
[http://dx.doi.org/10.1111/j.1442-9071.1997.tb01749.x] [PMID: 9267618]
[84]
Thakur, A.; Willcox, M.D. Chemotactic activity of tears and bacteria isolated during adverse responses. Exp. Eye Res., 1998, 66(2), 129-137.
[http://dx.doi.org/10.1006/exer.1997.0409] [PMID: 9533839]
[85]
Chao, C.; Akileswaran, L.; Cooke Bailey, J.N.; Willcox, M.; Van Gelder, R.; Lakkis, C.; Stapleton, F.; Richdale, K. Potential role of ocular microbiome, host genotype, tear cytokines, and environmental factors in corneal infiltrative events in contact lens wearers. Invest. Ophthalmol. Vis. Sci., 2018, 59(15), 5752-5761.
[http://dx.doi.org/10.1167/iovs.18-24845] [PMID: 30516819]
[86]
Grant, T.; Chong, M.S.; Vajdic, C.; Swarbrick, H.A.; Gauthier, C.; Sweeney, D.F.; Holden, B.A. Contact lens induced peripheral ulcers during hydrogel contact lens wear. CLAO J., 1998, 24(3), 145-151.
[PMID: 9684071]
[87]
Lorenzo-Morales, J.; Khan, N.A.; Walochnik, J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite, 2015, 22, 10.
[http://dx.doi.org/10.1051/parasite/2015010] [PMID: 25687209]
[88]
Carnt, N.; Montanez, V.M.; Galatowicz, G.; Veli, N.; Calder, V. Tear cytokine levels in contact lens wearers with Acanthamoeba Keratitis. Cornea, 2017, 36(7), 791-798.
[http://dx.doi.org/10.1097/ICO.0000000000001238] [PMID: 28489721]
[89]
Dionne, K.; Redfern, R.L.; Nichols, J.J.; Nichols, K.K. Analysis of tear inflammatory mediators: A comparison between the microarray and Luminex methods. Mol. Vis., 2016, 22, 177-188.
[PMID: 26957901]

Rights & Permissions Print Cite
Article Metrics
56
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy